MEDIA | NEWS

Bactana featured in http://www.news.cornell.edu
By Blaine Friedlander
Published: May 17, 2017

Bactana Animal Health, a new company providing a natural, sustainable alternative to dosing livestock prophylactically with antibiotics and hormones, joined Cornell’s McGovern Center for Venture Development in the Life Sciences earlier in May.

Patent covers core product discovery made at Cornell University

New Canaan, Connecticut – April 6 , 2017 – Bactana Animal Health, a company developing sustainable products aimed at reducing the use of antibiotics and hormones in the world’s food supply through immunomodulation and enhancement of the gut microbiota, today announced that Cornell University was issued a notice of allowance for U.S. Patent No. 14/380,881 entitled “Probiotic Compositions And Methods.” Bactana holds the exclusive worldwide license to this invention, which is the foundation of the company’s FPS-4™ product platform that was initially developed at Cornell University.

Bactana featured in Animal Pharm
By Joseph Harvey
Published: 29 March 2017 10:14 AM

Connecticut-based start-up Bactana Animal Health is developing a nutritional product platform designed to improve microbiome health in livestock and other animals. The company’s chief executive John Kallassy told Animal Pharm’s editor Joseph Harvey about the firm’s links with Cornell University and its attempts to cross the innovation chasm in animal health.

Company prepares for global launch of livestock antibiotic alternative

New Canaan, CT. – March 28, 2017 – Bactana Animal Health, a company developing natural products aimed at reducing the use of antibiotics and hormones in the world’s food supply through enhancement of the gut microbiota, today announced the closing of its first round of funding.